• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同取代位置的 F、Cl 原子在 5-甲基嘧啶吡啶衍生物苯环上对 EGFR 抑制剂抑制能力的影响:分子动力学模拟研究。

How Different Substitution Positions of F, Cl Atoms in Benzene Ring of 5-Methylpyrimidine Pyridine Derivatives Affect the Inhibition Ability of EGFR Inhibitors: A Molecular Dynamics Simulation Study.

机构信息

Laboratory of Theoretical and Computational Chemistry, Institute of Theoretical Chemistry, Jilin University, Changchun 130023, China.

Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Science, Jilin University, Changchun 130012, China.

出版信息

Molecules. 2020 Feb 18;25(4):895. doi: 10.3390/molecules25040895.

DOI:10.3390/molecules25040895
PMID:32085409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7071101/
Abstract

Lung cancer is the most frequent cause of cancer-related deaths worldwide, and mutations in the kinase domain of the epidermal growth factor receptor (EGFR) are a common cause of non-small-cell lung cancers, which is a major subtype of lung cancers. Recently, a series of 5-methylpyrimidine-pyridinone derivatives have been designed and synthesized as novel selective inhibitors of EGFR and EGFR mutants. However, the binding-based inhibition mechanism has not yet been determined. In this study, we carried out molecular dynamic simulations and free-energy calculations for EGFR derivatives to fill this gap. Based on the investigation, the three factors that influence the inhibitory effect of inhibitors are as follows: (1) The substitution site of the Cl atom is the main factor influencing the activity through steric effect; (2) The secondary factors are repulsion between the F atom (present in the inhibitor) and Glu762, and the blocking effect of Lys745 on the phenyl ring of the inhibitor. (3) The two factors function synergistically to influence the inhibitory capacity of the inhibitor. The theoretical results of this study can provide further insights that will aid the design of oncogenic EGFR inhibitors with high selectivity.

摘要

肺癌是全球癌症相关死亡的最常见原因,而表皮生长因子受体 (EGFR) 激酶结构域的突变是导致非小细胞肺癌的常见原因,非小细胞肺癌是肺癌的主要亚型之一。最近,一系列 5-甲基嘧啶-吡啶酮衍生物被设计和合成,作为新型 EGFR 和 EGFR 突变体的选择性抑制剂。然而,基于结合的抑制机制尚未确定。在这项研究中,我们对 EGFR 衍生物进行了分子动力学模拟和自由能计算,以填补这一空白。基于研究,影响抑制剂抑制效果的三个因素如下:(1)Cl 原子的取代位点是通过空间位阻影响活性的主要因素;(2)次要因素是抑制剂中存在的 F 原子与 Glu762 之间的排斥作用,以及 Lys745 对抑制剂芳环的阻碍作用。(3)这两个因素协同作用,影响抑制剂的抑制能力。本研究的理论结果可以提供进一步的见解,有助于设计具有高选择性的致癌 EGFR 抑制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/a1232878c588/molecules-25-00895-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/d6b149660cb9/molecules-25-00895-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/a137e76cdcb6/molecules-25-00895-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/b038d641e5e8/molecules-25-00895-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/6e4dc0a85f3e/molecules-25-00895-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/c4c60ecab902/molecules-25-00895-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/5d4b3f0f52c5/molecules-25-00895-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/376e48d87d18/molecules-25-00895-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/3830af022cc6/molecules-25-00895-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/8f8d46d64f10/molecules-25-00895-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/225bbf2511b6/molecules-25-00895-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/9840235f5897/molecules-25-00895-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/83d68fc2ee7a/molecules-25-00895-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/1d41ac3053fd/molecules-25-00895-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/a1232878c588/molecules-25-00895-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/d6b149660cb9/molecules-25-00895-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/a137e76cdcb6/molecules-25-00895-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/b038d641e5e8/molecules-25-00895-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/6e4dc0a85f3e/molecules-25-00895-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/c4c60ecab902/molecules-25-00895-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/5d4b3f0f52c5/molecules-25-00895-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/376e48d87d18/molecules-25-00895-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/3830af022cc6/molecules-25-00895-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/8f8d46d64f10/molecules-25-00895-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/225bbf2511b6/molecules-25-00895-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/9840235f5897/molecules-25-00895-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/83d68fc2ee7a/molecules-25-00895-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/1d41ac3053fd/molecules-25-00895-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f912/7071101/a1232878c588/molecules-25-00895-g014.jpg

相似文献

1
How Different Substitution Positions of F, Cl Atoms in Benzene Ring of 5-Methylpyrimidine Pyridine Derivatives Affect the Inhibition Ability of EGFR Inhibitors: A Molecular Dynamics Simulation Study.不同取代位置的 F、Cl 原子在 5-甲基嘧啶吡啶衍生物苯环上对 EGFR 抑制剂抑制能力的影响:分子动力学模拟研究。
Molecules. 2020 Feb 18;25(4):895. doi: 10.3390/molecules25040895.
2
Design, Synthesis, and Biological Evaluation of Pyrimido[4,5- d]pyrimidine-2,4(1 H,3 H)-diones as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation.嘧啶并[4,5- d]嘧啶-2,4(1 H,3 H)-二酮类作为有效的表皮生长因子受体(EGFR)抑制剂的设计、合成及生物评价:针对 L858R/T790M 耐药突变体。
J Med Chem. 2018 Jul 12;61(13):5609-5622. doi: 10.1021/acs.jmedchem.8b00346. Epub 2018 Jun 25.
3
Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors.用突变选择性变构抑制剂克服EGFR(T790M)和EGFR(C797S)耐药性。
Nature. 2016 Jun 2;534(7605):129-32. doi: 10.1038/nature17960. Epub 2016 May 25.
4
Noteworthy effect of slight variation in aliphatic chain length of trisubstituted imidazole inhibitors against epidermal growth factor receptor L858R/T790M/C797S mutant in cancer therapy.三取代咪唑抑制剂中脂肪链长度的微小变化对表皮生长因子受体 L858R/T790M/C797S 突变体在癌症治疗中的显著影响。
Chem Biol Drug Des. 2019 May;93(5):798-810. doi: 10.1111/cbdd.13467. Epub 2019 Jan 24.
5
Structural insight into the binding mechanism of ATP to EGFR and L858R, and T790M and L858R/T790 mutants.揭示 ATP 与 EGFR、L858R,以及 T790M 和 L858R/T790 突变体结合机制的结构见解。
J Biomol Struct Dyn. 2019 Oct;37(17):4671-4684. doi: 10.1080/07391102.2018.1558112. Epub 2019 Jan 11.
6
Structure-Based Drug Design Studies Toward the Discovery of Novel Chalcone Derivatives as Potential Epidermal Growth Factor Receptor (EGFR) Inhibitors.基于结构的药物设计研究,旨在发现新型查尔酮衍生物作为潜在的表皮生长因子受体 (EGFR) 抑制剂。
Molecules. 2018 Dec 5;23(12):3203. doi: 10.3390/molecules23123203.
7
Design, synthesis and anticancer evaluation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as potent EGFR and EGFR inhibitors and apoptosis inducers.设计、合成及抗癌评估 1H-吡唑并[3,4-d]嘧啶衍生物作为有效 EGFR 和 EGFR 抑制剂及凋亡诱导剂。
Bioorg Chem. 2018 Oct;80:375-395. doi: 10.1016/j.bioorg.2018.06.017. Epub 2018 Jun 12.
8
A Mechanistic Study of a Potent and Selective Epidermal Growth Factor Receptor Inhibitor against the L858R/T790M Resistance Mutation.一种针对 L858R/T790M 耐药突变的强效和选择性表皮生长因子受体抑制剂的机制研究。
Biochemistry. 2019 Oct 15;58(41):4246-4259. doi: 10.1021/acs.biochem.9b00710. Epub 2019 Oct 7.
9
Structural optimization of diphenylpyrimidine scaffold as potent and selective epidermal growth factor receptor inhibitors against L858R/T790M resistance mutation in nonsmall cell lung cancer.二苯嘧啶骨架的结构优化作为非小细胞肺癌中针对 L858R/T790M 耐药突变的有效和选择性表皮生长因子受体抑制剂。
Chem Biol Drug Des. 2018 Dec;92(6):1988-1997. doi: 10.1111/cbdd.13370. Epub 2018 Aug 26.
10
Discovery of 5-(methylthio)pyrimidine derivatives as L858R/T790M mutant selective epidermal growth factor receptor (EGFR) inhibitors.5-(甲硫基)嘧啶衍生物作为L858R/T790M突变型选择性表皮生长因子受体(EGFR)抑制剂的发现
Bioorg Med Chem. 2016 Jun 15;24(12):2673-80. doi: 10.1016/j.bmc.2016.04.032. Epub 2016 Apr 19.

引用本文的文献

1
A momentous progress update: epidermal growth factor receptor inhibitors as viable agents for combating cancer.一项重大进展更新:表皮生长因子受体抑制剂作为抗癌的可行药物。
RSC Med Chem. 2025 Jul 7. doi: 10.1039/d4md00799a.
2
Recent Applications of In Silico Approaches for Studying Receptor Mutations Associated with Human Pathologies.近年来,基于计算机的方法在研究与人类疾病相关的受体突变中的应用。
Molecules. 2024 Nov 13;29(22):5349. doi: 10.3390/molecules29225349.
3
Rational Design of Non-Covalent Imprinted Polymers Based on the Combination of Molecular Dynamics Simulation and Quantum Mechanics Calculations.

本文引用的文献

1
The Role of EGFR in Influenza Pathogenicity: Multiple Network-Based Approaches to Identify a Key Regulator of Non-lethal Infections.表皮生长因子受体在流感致病性中的作用:基于多种网络的方法来识别非致死性感染的关键调节因子
Front Cell Dev Biol. 2019 Sep 20;7:200. doi: 10.3389/fcell.2019.00200. eCollection 2019.
2
Structure-Based Design of 5-Methylpyrimidopyridone Derivatives as New Wild-Type Sparing Inhibitors of the Epidermal Growth Factor Receptor Triple Mutant (EGFR).基于结构的 5-甲基嘧啶并吡啶酮衍生物的设计,作为新型野生型表皮生长因子受体三突变体(EGFR)的节约抑制剂。
J Med Chem. 2019 Aug 8;62(15):7302-7308. doi: 10.1021/acs.jmedchem.9b00576. Epub 2019 Jul 23.
3
基于分子动力学模拟与量子力学计算相结合的非共价印迹聚合物的合理设计
Polymers (Basel). 2024 Aug 9;16(16):2257. doi: 10.3390/polym16162257.
4
SPOP regulates the expression profiles and alternative splicing events in human hepatocytes.SPOP调节人类肝细胞中的表达谱和可变剪接事件。
Open Life Sci. 2023 Oct 24;18(1):20220755. doi: 10.1515/biol-2022-0755. eCollection 2023.
5
Mechanism Exploration of Amyloid-β-42 Disaggregation by Single-Chain Variable Fragments of Alzheimer's Disease Therapeutic Antibodies.阿尔茨海默病治疗性抗体单链可变片段对淀粉样β-42 解聚的机制探索。
Int J Mol Sci. 2023 May 6;24(9):8371. doi: 10.3390/ijms24098371.
Discovery of Potent and Noncovalent Reversible EGFR Kinase Inhibitors of EGFR.
表皮生长因子受体(EGFR)强效非共价可逆激酶抑制剂的发现
ACS Med Chem Lett. 2019 May 22;10(6):869-873. doi: 10.1021/acsmedchemlett.8b00564. eCollection 2019 Jun 13.
4
Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor.单靶点和双靶点突变型 EGFR 的变构抑制剂
Cancer Discov. 2019 Jul;9(7):926-943. doi: 10.1158/2159-8290.CD-18-0903. Epub 2019 May 15.
5
Exploration of Catalytic Selectivity for Aminotransferase (BtrR) Based on Multiple Molecular Dynamics Simulations.基于多种分子动力学模拟的转氨酶(BtrR)催化选择性研究。
Int J Mol Sci. 2019 Mar 8;20(5):1188. doi: 10.3390/ijms20051188.
6
Noteworthy effect of slight variation in aliphatic chain length of trisubstituted imidazole inhibitors against epidermal growth factor receptor L858R/T790M/C797S mutant in cancer therapy.三取代咪唑抑制剂中脂肪链长度的微小变化对表皮生长因子受体 L858R/T790M/C797S 突变体在癌症治疗中的显著影响。
Chem Biol Drug Des. 2019 May;93(5):798-810. doi: 10.1111/cbdd.13467. Epub 2019 Jan 24.
7
Design and Evaluation of Potent EGFR Inhibitors through the Incorporation of Macrocyclic Polyamine Moieties into the 4-Anilinoquinazoline Scaffold.通过将大环多胺部分引入 4-苯胺基喹唑啉支架来设计和评估有效的 EGFR 抑制剂。
J Med Chem. 2018 Dec 27;61(24):11372-11383. doi: 10.1021/acs.jmedchem.8b01612. Epub 2018 Dec 14.
8
Insight into binding mechanisms of EGFR allosteric inhibitors using molecular dynamics simulations and free energy calculations.使用分子动力学模拟和自由能计算深入了解 EGFR 变构抑制剂的结合机制。
J Biomol Struct Dyn. 2019 Oct;37(16):4384-4394. doi: 10.1080/07391102.2018.1552197. Epub 2019 Jan 11.
9
Effects of Tyr555 and Trp678 on the processivity of cellobiohydrolase A from Ruminiclostridium thermocellum: A simulation study.酪蛋白水解酶A的Tyr555和Trp678对嗜热栖热放线菌纤维二糖水解酶持续性的影响:一项模拟研究。
Biopolymers. 2018 Dec;109(12):e23238. doi: 10.1002/bip.23238. Epub 2018 Nov 28.
10
Epidermal Growth Factor Receptor Gene in Non-Small-Cell Lung Cancer: The Importance of Promoter Polymorphism Investigation.非小细胞肺癌中的表皮生长因子受体基因:启动子多态性研究的重要性。
Anal Cell Pathol (Amst). 2018 Oct 14;2018:6192187. doi: 10.1155/2018/6192187. eCollection 2018.